Anzeige
❌
Mehr »
Mittwoch, 14.10.2026 - Börsentäglich über 12.000 News
35 Millionen C$ Einsatz gegenüber 13 Millionen C$ erwartetem Gewinn für 2027
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESS Newswire
219 Leser
Artikel bewerten:
(1)

Nutranomics Inc.: NutraNomics, Inc. Announces Developments Relating To Acquisition of DHS Development dba The Plant

PORTLAND, OR / ACCESSWIRE / April 5, 2022 / NutraNomics, Inc. (OTC PINK:NNRX) is pleased to share the following development news relating to the acquisition of DHS Development, Inc. dba The Plant.

As a formal follow-up to the terms of the definitive merger agreement recently executed between NutraNomics and The Plant, the parties have been working closely and exchanging deliverables to officially move the newly merged organization forward in preparation for the formal closing. In the coming weeks, we look forward to sharing operational strategies as production transitions into the new facility, additional equipment assets are acquired and activated, and the hiring of key personnel critical to the organization are put into place.

The combined organization is successfully capitalizing on the momentum established by The Plant over the course of the past few years. Powered by the influx of $1.1M of interim capital, the organization has been able to onboard new sales agreements, develop and manufacture additional products and services, and scale existing production capabilities. The Company is positioned for production across a suite of several new complimentary products, and is poised to accommodate additional client demand. The interim capital has already empowered the generation of significant additional revenue with more growth on the horizon. Sherratt Reicher, The Plant's Sr. Vice President of Business Development says, "We have been encouraged and excited about the immediate results and synergies of both organizations working together so far." Geoff Bazegian, NutraNomics' President and CRO states, "These immediate results are defining a prosperous future, with outstanding prospects for collaboration on future growth. We couldn't be better positioned."

The Plant and its subsidiaries have been diligent, responsive and impactful in the years prior to the engagement with NutraNomics. The Plant's raising of capital for the construction of the 28,000 sq. ft. manufacturing facility, the pursuit of premier licensing, the acquisition of essential production equipment, and the on-boarding of key partners and personnel, have all led up to the formation of something very special coming into the acquisition. The millions of dollars of combined capital infusion by The Plant and NutraNomics will prove to be the spring board to net positive results in 2022 and 2023. Jonathan Bishop, CEO and Chairman of NutraNomics states, "This will be the catalyst that will drive the organization to be among an elite group of the most innovative cannabis manufacturers and cultivators in the State of California and across the country"

More details to come throughout the month of April.

Forward-Looking Statements

Any statements made in this press release which are not historical facts contain certain forward-looking statements; as such term is defined in the Private Security Litigation Reform Act of 1995, concerning potential developments affecting the business, prospects, financial condition and other aspects of the company to which this release pertains. The actual results of the specific items described in this release, and the company's operations generally, may differ materially from what is projected in such forward-looking statements. Although such statements are based upon the best judgments of management of the company as of the date of this release, significant deviations in magnitude, timing and other factors may result from business risks and uncertainties including, without limitation, the company's dependence on third parties, general market and economic conditions, technical factors, the availability of outside capital, receipt of revenues and other factors, many of which are beyond the control of the company. The company disclaims any obligation to update the information contained in any forward-looking statement. This press release shall not be deemed a general solicitation.

Contact: Geoff Bazegian, IR@nutranomics.com

SOURCE: NutraNomics, Inc.



View source version on accesswire.com:
https://www.accesswire.com/696057/NutraNomics-Inc-Announces-Developments-Relating-To-Acquisition-of-DHS-Development-dba-The-Plant

© 2022 ACCESS Newswire
KI-Euphorie kippt - Bei diesen 5 Aktien droht der Crash!
Drei Jahre lang kannten KI-Aktien fast nur eine Richtung: nach oben. Billionenschwere Investitionspläne von Alphabet, Amazon, Meta und Microsoft haben Halbleiter- und Infrastrukturwerte auf immer neue Höhen getrieben. Doch jetzt bekommt die Erfolgsstory gefährliche Risse.

Steigende Anleiherenditen verteuern die Finanzierung, während die gewaltigen KI-Ausgaben zunehmend nicht mehr aus den laufenden Cashflows bezahlt werden können. Gleichzeitig zeigen günstigere chinesische Modelle, dass leistungsfähige KI womöglich mit deutlich weniger Rechenleistung auskommt. Damit wächst die Gefahr, dass heute für Milliarden errichtete Kapazitäten morgen nicht die erhofften Renditen liefern.

Für Anleger könnte das zum Problem werden. Denn treffen steigende Finanzierungskosten auf Überkapazitäten und enttäuschende Cashflows, geraten gerade hoch bewertete KI-Profiteure schnell unter Druck. Aus den größten Gewinnern der vergangenen Jahre könnten so die größten Verlierer der nächsten Korrektur werden.

In unserem aktuellen Spezialreport zeigen wir 5 Aktien, bei denen das Chance-Risiko-Verhältnis jetzt besonders gefährlich erscheint – und bei denen Anleger genauer hinschauen sollten.

Jetzt den kostenlosen Report sichern – bevor die KI-Euphorie ihren nächsten Realitätstest erlebt!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.